Bearish flow noted in Crispr Therapeutics with 7,080 puts trading, or 8x expected. Most active are 11/3 weekly 38 puts and Nov-23 45 calls, with total volume in those strikes near 6,100 contracts. The Put/Call Ratio is 1.80, while ATM IV is up over 9 points on the day. Earnings are expected on October 31st.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CRSP:
- Crispr exa-cel AdCom briefing docs a ‘possible best case,’ says Mizuho
- FDA staff raise concerns about Vertex, Crispr sickle cell therapy safety data
- Citi opens ‘positive catalyst watch’ on Crispr Therapeutics, Beam Therapeutics
- Cathie Wood’s ARK Investment bought 201K shares of Crispr Therapeutics today
- Dollar Tree upgraded, Microsoft initiated: Wall Street’s top analyst calls